These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15678114)

  • 21. Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery.
    Kawano K; Ikeda Y; Kondo K; Umemura K
    Eur J Pharmacol; 1999 Jun; 374(3):377-85. PubMed ID: 10422782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of progressive stroke with tirofiban--experience in 35 patients.
    Philipps J; Thomalla G; Glahn J; Schwarze M; Rother J
    Cerebrovasc Dis; 2009; 28(5):435-8. PubMed ID: 19738371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
    Dohare P; Garg P; Jain V; Nath C; Ray M
    Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases.
    Junghans U; Seitz RJ; Wittsack HJ; Aulich A; Siebler M
    Radiology; 2001 Dec; 221(3):795-801. PubMed ID: 11719681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tirofiban and emergency coronary surgery.
    Shanmugam G
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):546-50. PubMed ID: 16126403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human thrombocytes are able to induce a myocardial dysfunction in the ischemic and reperfused guinea pig heart mediated by free radicals-role of the GPIIb/IIIa-blocker tirofiban.
    Seligmann C; Simsek Y; Schimmer M; Leitsch T; Bock A; Schultheiss HP
    Life Sci; 2002 Sep; 71(19):2319-29. PubMed ID: 12215379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of platelets by the GPIIb/IIIa receptor antagonist Tirofiban reduces leukocyte-endothelial cell interaction in murine antigen-induced arthritis.
    Schmitt-Sody M; Metz P; Gottschalk O; Zysk S; Birkenmaier C; Goebl M; von Schulze Pellengahr C; Veihelmann A; Jansson V
    Inflamm Res; 2007 Oct; 56(10):414-20. PubMed ID: 18026698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion.
    Ritter LS; Stempel KM; Coull BM; McDonagh PF
    Biol Res Nurs; 2005 Apr; 6(4):281-8. PubMed ID: 15788737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.
    Kawano KI; Hokamura K; Kondo K; Ikeda Y; Suzuki Y; Umemura K
    Eur J Pharmacol; 2001 Apr; 417(3):217-22. PubMed ID: 11334853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.
    Zhang ZG; Zhang L; Tsang W; Goussev A; Powers C; Ho KL; Morris D; Smyth SS; Coller BS; Chopp M
    Brain Res; 2001 Sep; 912(2):181-94. PubMed ID: 11532435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
    Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
    Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and structure-activity relationships of potent GPIIb/IIIa antagonists: discovery of FK419.
    Yamanaka T; Ohkubo M; Kuroda S; Nakamura H; Takahashi F; Aoki T; Mihara K; Seki J; Kato M
    Bioorg Med Chem; 2005 Jul; 13(13):4343-52. PubMed ID: 15927840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.
    Peerlinck K; De Lepeleire I; Goldberg M; Farrell D; Barrett J; Hand E; Panebianco D; Deckmyn H; Vermylen J; Arnout J
    Circulation; 1993 Oct; 88(4 Pt 1):1512-7. PubMed ID: 8403299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events.
    Dunkley S; Evans S; Gaudry L; Jepson N
    Platelets; 2005 Dec; 16(8):462-8. PubMed ID: 16287613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
    Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
    J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet function monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration.
    Tucci MA; Ganter MT; Hamiel CR; Klaghofer R; Zollinger A; Hofer CK
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1314-22. PubMed ID: 16733164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study.
    Kunichika H; Ben-Yehuda O; Lafitte S; Kunichika N; Peters B; DeMaria AN
    J Am Coll Cardiol; 2004 Jan; 43(2):276-83. PubMed ID: 14736449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats.
    Ríos C; Nader-Kawachi J; Rodriguez-Payán AJ; Nava-Ruiz C
    Brain Res; 2004 Mar; 999(2):212-5. PubMed ID: 14759500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.